Showing 1 - 19 results of 19 for search 'Daniele Marinelli', query time: 0.07s
Refine Results
-
1
-
2
Non-small-cell lung cancer: how to manage ALK-, ROS1- and NTRK-rearranged disease by Daniele Marinelli, Marco Siringo, Giulio Metro, Biagio Ricciuti, Alain J Gelibter
Published 2022-10-01
Article -
3
Spectral separability of bark beetle infestation stages: A single-tree time-series analysis using Planet imagery by Michele Dalponte, Ruggero Cetto, Daniele Marinelli, Davide Andreatta, Cristina Salvadori, Francesco Pirotti, Lorenzo Frizzera, Damiano Gianelle
Published 2023-09-01
Article -
4
PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis by Michela Roberto, Mattia Alberto Di Civita, Daniele Marinelli, Andrea Torchia, Nertila Cara, Giulia Maltese, Iolanda Speranza, Daniele Santini
Published 2025-01-01
Article -
5
Multiyear Mapping of Water Demand at Crop Level: An End-to-End Workflow Based on High-Resolution Crop Type Maps and Meteorological Data by Giulio Weikmann, Daniele Marinelli, Claudia Paris, Silke Migdall, Eva Gleisberg, Florian Appel, Heike Bach, Jim Dowling, Lorenzo Bruzzone
Published 2023-01-01
Article -
6
Comparison of Two Blood-Based Genotyping Tests to Investigate the KRAS G12C Mutation in Patients with Non-Small-Cell Lung Cancer at Failure of First-Line Treatments by Chiara Nicolazzo, Alain Gelibter, Irene Bottillo, Francesca Belardinilli, Simona Pisegna, Gianluigi De Renzi, Daniele Marinelli, Paola Grammatico, Enrico Cortesi, Giuseppe Giannini, Paola Gazzaniga
Published 2021-11-01
Article -
7
Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) in Luminal Breast Cancer: A Retrospective Analysis in the Neoadjuvant Setting by Antonino Grassadonia, Vincenzo Graziano, Laura Iezzi, Patrizia Vici, Maddalena Barba, Laura Pizzuti, Giuseppe Cicero, Eriseld Krasniqi, Marco Mazzotta, Daniele Marinelli, Antonella Amodio, Clara Natoli, Nicola Tinari
Published 2021-07-01
Article -
8
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC by Filippo Tommaso Gallina, Daniele Marinelli, Riccardo Tajè, Daniele Forcella, Gabriele Alessandrini, Fabiana Letizia Cecere, Francesca Fusco, Paolo Visca, Isabella Sperduti, Vincenzo Ambrogi, Federico Cappuzzo, Enrico Melis, Francesco Facciolo
Published 2023-11-01
Article -
9
Tissue- and liquid-biopsy based NGS profiling in advanced non-small-cell lung cancer in a real-world setting: the IMMINENT study by Marco Sposito, Lorenzo Belluomini, Riccardo Nocini, Jessica Insolda, Ilaria Mariangela Scaglione, Jessica Menis, Michele Simbolo, Antonio Lugini, Federica Buzzacchino, Francesco Verderame, Francesca Spinnato, Giuseppe Aprile, Lorenzo Calvetti, Mario Occhipinti, Mario Occhipinti, Daniele Marinelli, Daniele Marinelli, Antonello Veccia, Fiorella Lombardo, Hector José Soto Parra, Francesco Ferraù, Clementina Savastano, Camilla Porta, Lorenzo Pradelli, Emilia Sicari, Silvia Castellani, Umberto Malapelle, Silvia Novello, Emilio Bria, Emilio Bria, Sara Pilotto, Michele Milella
Published 2024-07-01
Article -
10
Advanced non-small-cell lung cancer: how to manage EGFR and HER2 exon 20 insertion mutation-positive disease by Giulio Metro, Andrea De Giglio, Biagio Ricciuti, Marco Siringo, Daniele Marinelli, Alain Gelibter, Federica Pecci, Rossana Berardi, Luca Cantini, Alessandro Di Federico, Elisa Andrini, Mirta Mosca, Giuseppe Lamberti, Marta Brambilla, Giannis Mountzios
Published 2022-07-01
Article -
11
Nodal Upstaging Evaluation After Robotic-Assisted Lobectomy for Early-Stage Non-small Cell Lung Cancer Compared to Video-Assisted Thoracic Surgery and Thoracotomy: A Retrospective... by Filippo Tommaso Gallina, Enrico Melis, Daniele Forcella, Edoardo Mercadante, Daniele Marinelli, Serena Ceddia, Federico Cappuzzo, Sabrina Vari, Fabiana Letizia Cecere, Mauro Caterino, Antonello Vidiri, Paolo Visca, Simonetta Buglioni, Isabella Sperduti, Mirella Marino, Francesco Facciolo
Published 2021-07-01
Article -
12
Immunotherapy-Based Combinations in First-Line Urothelial Cancer: A Systematic Review and Individual Patient Data (IPD) Meta-Analysis by Mattia Alberto Di Civita, Andrea Torchia, Daniele Santini, Daniele Marinelli, Virginia Magro, Marianna Cerro, Laura Pappalardo, Giulia Maltese, Fiorenza Santamaria, Luca Zacco, Dorelsa Buccilli, Ailin Dehghanpour, Iolanda Speranza, Alessandro Sciarra, Valeria Panebianco, Michela Roberto
Published 2024-08-01
Article -
13
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis by Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco De Vincentiis, Valentino Valentini, Silvia Mezi, Filippo Valentini, Luca Vivona, Antonella Chiavassa, Bruna Cerbelli, Daniele Santini, Paolo Bossi, Antonella Polimeni, Paolo Marchetti, Andrea Botticelli
Published 2024-04-01
Article -
14
Correction: Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis by Alessio Cirillo, Daniele Marinelli, Umberto Romeo, Daniela Messineo, Francesca De Felice, Marco De Vincentiis, Valentino Valentini, Silvia Mezi, Filippo Valentini, Luca Vivona, Antonella Chiavassa, Bruna Cerbelli, Daniele Santini, Paolo Bossi, Antonella Polimeni, Paolo Marchetti, Andrea Botticelli
Published 2024-04-01
Article -
15
TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients by Roberto Dinami, Manuela Porru, Carla Azzurra Amoreo, Isabella Sperduti, Marcella Mottolese, Simonetta Buglioni, Daniele Marinelli, Marcello Maugeri-Saccà, Andrea Sacconi, Giovanni Blandino, Carlo Leonetti, Giuliana Di Rocco, Alessandra Verdina, Francesca Spinella, Francesco Fiorentino, Gennaro Ciliberto, Annamaria Biroccio, Pasquale Zizza
Published 2020-06-01
Article -
16
Weekly carboplatin plus paclitaxel chemotherapy in advanced melanoma patients resistant to anti-PD-1 inhibitors: a retrospective, monocentric experience by Francesca Romana Di Pietro, Daniele Marinelli, Sofia Verkhovskaia, Giulia Poti, Rosa Falcone, Maria Luigia Carbone, Maria Francesca Morelli, Albina Rita Zappalà, Zorika Christiana Di Rocco, Roberto Morese, Gabriele Piesco, Paolo Chesi, Paolo Marchetti, Cristina Maria Failla, Federica De Galitiis
Published 2024-10-01
Article -
17
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes by Gennaro Ciliberto, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Matteo Pallocca, Irene Terrenato, Marco Mazzotta, Mario Occhipinti, Daniele Marinelli, Stefano Scalera, Francesca Sperati, Francesco Rizzo, Giorgia Scafetta, Arianna Di Napoli, Eriseld Krasniqi, Laura Pizzuti, Maddalena Barba, Silvia Carpano, Patrizia Vici, Maurizio Fanciulli, Francesca De Nicola, Ludovica Ciuffreda, Frauke Goeman, Ruggero De Maria, Andrea Vecchione, Marcello Maugeri-Saccà
Published 2020-10-01
Article -
18
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study by Giulia Bon, Laura Pizzuti, Valentina Laquintana, Rossella Loria, Manuela Porru, Caterina Marchiò, Eriseld Krasniqi, Maddalena Barba, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Giacomo Barchiesi, Marco Mazzotta, Daniele Marinelli, Silverio Tomao, Paolo Marchetti, Maria Rosaria Valerio, Rosanna Mirabelli, Antonio Russo, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Francesco Giotta, Carlo Garufi, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Giuseppe Sanguineti, Isabella Sperduti, Anna Sapino, Ruggero De Maria, Carlo Leonetti, Angelo Di Leo, Gennaro Ciliberto, Rita Falcioni, Patrizia Vici
Published 2020-12-01
Article -
19
The prognostic relevance of HER2-positivity gain in metastatic breast cancer in the ChangeHER trial by Laura Pizzuti, Maddalena Barba, Marco Mazzotta, Eriseld Krasniqi, Marcello Maugeri-Saccà, Teresa Gamucci, Rossana Berardi, Lorenzo Livi, Corrado Ficorella, Clara Natoli, Enrico Cortesi, Daniele Generali, Nicla La Verde, Alessandra Cassano, Emilio Bria, Luca Moscetti, Andrea Michelotti, Vincenzo Adamo, Claudio Zamagni, Giuseppe Tonini, Domenico Sergi, Daniele Marinelli, Giancarlo Paoletti, Silverio Tomao, Andrea Botticelli, Paolo Marchetti, Nicola Tinari, Antonino Grassadonia, Maria Rosaria Valerio, Rosanna Mirabelli, Maria Agnese Fabbri, Nicola D’Ostilio, Enzo Veltri, Domenico Corsi, Ornella Garrone, Ida Paris, Giuseppina Sarobba, Icro Meattini, Mirco Pistelli, Francesco Giotta, Vito Lorusso, Carlo Garufi, Antonio Russo, Marina Cazzaniga, Pietro Del Medico, Mario Roselli, Angela Vaccaro, Letizia Perracchio, Anna di Benedetto, Theodora Daralioti, Isabella Sperduti, Ruggero De Maria, Angelo Di Leo, Giuseppe Sanguineti, Gennaro Ciliberto, Patrizia Vici
Published 2021-07-01
Article